Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (733) dutasteride, GlaxoSmithKline,
...FDA for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland. Dutasteride is a dual 5-alpha-reductase inhibitor, blocking both type 1 and type 2 ...
View Page

2.  Study Posting (2348) Trial #37780, Prostate Cancer, New York, NY
...travel expenses. Compensation Provided Patient Inclusion/Exclusion Criteria: Diagnosis of localized prostate cancer (in the prostate gland only) OR FOR COMPARISON CONTROL GROUP: Prostate Specific Antigen < 4ng./dl Advanced or metastatic prostate ...
View Page

3.  Study Posting (2348) Trial #94804, Prostate Disorders, New York, NY
...to evaluate if the study drug, tadalafil, will improve the signs and symptoms of enlarged prostate gland (also known as benign prostatic hyperplasia or BPH). This study will also aim to show ...
View Page

4.  Study Posting (2246) Trial #129810, Prostate Cancer, Duarte, CA
...stable state and has never recurred, progressed, or metastasized (spread beyond the area of the prostate gland). Additionally, you were at least 22 years of age at the time of diagnosis and ...
View Page

5.  Study Posting (2750) Trial #72143, Prostatic Intraepithelial Neoplasia, Las Vegas, NV
...high grade prostatic intraepithelial neoplasia (PIN). PIN is the presence of abnormal tissue in the prostate gland that may lead to cancer of the prostate. The age range is 30 years and ...
View Page

6.  Study Posting (1768) Trial #68457, Urinary Tract Infections, Staten Island, NY
...of an investigational drug used to treat lower urinary tract symptoms secondary to an enlarged prostate gland. Men with these conditions for longer than 6 months who are 45 or older may ...
View Page

7.  Study Posting (3115) Trial #118869, Prostate Disorders, New York, NY
...of an investigational drug used to treat lower urinary tract symptoms secondary to an enlarged prostate gland. Men with these conditions for longer than 6 months who are 45 or older may ...
View Page

8.  Study Posting (2348) Trial #39500, Prostate Cancer, New York, NY
...evaluated by one of the following: a)Presence of metastatic (outside the area of the prostate gland) disease on bone scan, CT scan or MRI; b) Presence of growing prostate cancer found ...
View Page

9.  Study Posting (2348) Trial #55131, Prostate Cancer, New York, NY
...prostate cancer involvement of the seminal vesicles. 3. Prostate cancer which has spread outside the prostate gland detected by x-ray, CT scan or magnetic resonance imaging. 4. Previous history of radiation ...
View Page

10.  Newly Approved Drug Therapies (846) Plenaxis (abarelix for injectable suspension), Praecis Pharmaceuticals,
...al. Abarelix (PPI-149), a novel and potent GnRH antagonist, induces a rapid and profound prostate gland volume reduction (PGVR) and androgen suppression before brachytherapy (BT) or radiation therapy (XRT). J Urol ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (36), Prostate Cancer
...the six subjects. In a fifth patient, the PSA level dropped by 53% and the prostate gland shrank by 67% from just prior to treatment to the time of surgical removal. The ...
View Page